The Usher syndromes are a group of autosomal recessive disorders characterised by retinitis pigmentosa (RP) with sensorineural hearing loss and variable vestibular areflexia. There is extensive clinical and genetic heterogeneity in Usher syndrome. The distinguishing characteristics of Usher type I are profound hearing loss and vestibular dysfunction. Moderate to severe high frequency hearing loss and normal vestibular function are representative of Usher type II. Progressive hearing loss is typically seen in Usher type III. 1 2 Usher III appears to be relatively common in the Finnish Usher population, but rare elsewhere 3 ; the USH3 gene has been localised to 3q25. 4 The clinical picture of Usher syndrome type II is complicated because subtle variations within the Usher II hearing phenotype have been observed in several Dutch studies. In the first, three of 13 type II patients had a mild but definite progression of hearing loss unrelated to presbycusis; these three families showed linkage to USH2A and not to USH3. 5 A subsequent cross sectional study was done with 27 patients whose status as Usher type IIa had also been confirmed by linkage analysis. When hearing threshold was compared against age, significant progression of hearing impairment was observed, but at a much slower rate than previously reported for Usher III patients. 6 All putative Usher II families should be excluded from linkage to USH3 to negate the possibility of phenotypic overlap between the two subtypes. Good quality serial audiograms (when available) can be used in conjunction with linkage analysis to distinguish between Usher IIa and Usher III in some cases.
Mutations in the USH2A gene on chromosome 1q41 appear to be responsible for most cases of Usher type II. 7 The gene has 21 exons and codes for usherin, a novel protein whose structure is partially homologous with the laminin protein group. The function of usherin is not yet understood but it has been postulated that it is a cell adhesion molecule or forms part of the basement membrane. The genomic structure of USH2A has been determined and several new USH2A mutations have recently been found. 8 Genetic heterogeneity within the Usher II subtype was first noticed when a family with an Usher II phenotype (family 735) was found to be unlinked to 1q41 markers flanking the USH2A locus. 9 A subsequent heterogeneity study of 29 Usher II Dutch families identified three that were unlinked to the USH2A region. 10 There was no evidence of significant linkage to 3q25 (USH3) in this specific sample. A preliminary study of the proportion of diVerent linkages in a sample of pooled Usher type II and type III families showed that 82% showed linkage to USH2A and 12% showed linkage to USH3, but 3.4% were unlinked to both 1q and 3q. 11 The question remained as to exactly where this new Usher II gene was located in the human genome. The previous studies had identified several unlinked Usher II families, but these were too small and uninformative for a productive genome search. Then, an unlinked family (1848) with multiple aVected sibs and a retinal phenotype almost identical to that of family 735 was discovered. These two highly informative families were chosen for the genome search.
Methods

CLINICAL STUDIES
Families with clinical diagnoses of Usher II were ascertained through physician's referral and self-referral. The specific audiometric, vestibular, and ophthalmic criteria used for a clinical diagnosis of Usher type I and type II have been previously described. 1 12 The average Usher II patient will present with (1) RP, symptoms include nyctalopia, an extinguished or subnormal electroretinogram (ERG), and restricted visual fields; (2) congenital, relatively stable, "sloping" hearing loss, moderate in the low frequencies and severe in the higher frequencies; (3) intact vestibular responses; and (4) autosomal recessive inheritance pattern.
DNA AND PCR MARKERS
Blood samples were collected and DNA was extracted from lymphocytes using the PureGene DNA extraction kit (Gentra Systems Inc) according to the vendor's instructions. ABI Prism marker panels (Version 1, Perkin Elmer Inc) that spanned the entire genome at approximately 10 cM intervals were purchased for the genome search. Additional PCR markers were later chosen based on chromosomal position, heterozygosity index, and fragment size for the purpose of linkage mapping. PCR primer sequences were obtained from (1) Marker data were analysed with the LINK-AGE program package, version 5.1.
14 Both two point and a rolling multipoint analysis were performed. The rolling multipoint analysis was done using overlapping sets of four contiguous marker loci with the test locus (five point analysis). Multipoint lod scores are calculated at approximately 0.5 cM intervals for each family. An A test of heterogeneity was performed on both two point and multipoint lod scores using HOMOG. 15 The frequency of the Lod score Usher II gene was arbitrarily set at 0.005 and penetrance in the mutant homozygote was assumed to be complete.
Results
A genome search was done with families 735 and 1848 using the ABI Prism 1 panels. Two point lod scores were generated for each marker until significant linkages on chromosome 5q were detected. The study was then expanded to include smaller unlinked families. In a preliminary report, we announced that Usher type II in 735, 1848, and two other families was linked to chromosome 5q14.3-q21.3 with a combined two point lod score over 3.1 at D5S484. 16 To date, 12 unlinked families have been evaluated for linkage to 5q with the seven markers listed in table 1. A combined two point lod score of 4.49 was observed at marker D5S484 ( max=0.05). Two point lod scores for each marker were then analysed by the A test for heterogeneity and the results for (the proportion of linked families) and 2 are shown in the last two columns of table 1. The test for linkage heterogeneity v homogeneity with linkage was significant for D5S495 and D5S505, with The multipoint maximum lod score for this sample was 5.86 observed between D5S617 and D5S484 (fig 1) . Multipoint lod scores between D5S495 and D5S505 were analysed by the A test for heterogeneity, yielding a significant 2 (1) =26.9 (p<0.001), establishing that both 5q linked and unlinked families were present in this sample. The proportion of 5q linked families in this sample was estimated to be 0.68.
Conditional probabilities obtained from the HOMOG program for all 12 families are listed in table 2. Three families were highly informative and the probability of linkage to 5q markers for families 735, 1848, and 964 was estimated to be over 98% in each case. Six smaller, less informative families scored probabilities ranging from 92-74%. Conditional probabilities of 0.0 were observed for families 49 and 1322; neither show linkage to any known Usher locus. Family 843 is small (one parent, sibship of two with one aVected and one unaVected oVspring), but the proband has the distinctive phenotype similar to that of family 49.
A diagnosis of RP was first established between the ages of 28 and 32 in six of the 5q linked families. Only the first diagnosed sib was considered because it was obvious that the age at diagnosis within a given family could be influenced by a positive family history. Remarkably, in family 1848, the sib diagnosed with RP at 32 years had an ERG that was diminished but not completely extinguished and the oldest sister had retained a visual field of 20°by the age of 39. An aVected sib from family 964 retained 20°of vision by the age of 40 as well.
In sharp contrast, aVected sibs from families 49 and 843 have been aZicted with nystagmus D5S428  D5S617  D5S618  D5S644  D5S484  D5S495  D5S456  D5S409  D5S505  D5S654  D5S485  D5S433   D5S2029   D5S2084  D5S2051  D5S1965   208   252  177  176   283  243  109  152  135  270  272   95   75   143   126  178  246   272  214   242  177  176  97  283  235  109  152  137  260  272 The degree of hearing loss in each family coincided with the extent of variation typically seen for Usher type II. 9 Hearing loss ranged from moderate to severe in the lower frequencies and severe to profound in the higher frequencies in the nine 5q linked families. All three unlinked families had severe to profound hearing loss. Serial audiograms were not currently available for all 12 families, so the possibility of slowly progressive hearing loss unrelated to presbycusis could not be tested for the entire group. However, serial audiograms for 5q linked family 1121 did provide evidence for a slowly progressive hearing loss, similar to that described for patients with USH2a. 5 6 No significant vestibular anomalies were reported for any of the 12 families. Surprisingly, two of three unlinked families had enamel hypoplasia, a standard clinical feature of no known Usher subtype. The teeth were described as small, brownish, or peg-like. X rays showed enamel hypoplasia; the teeth tend to be "soft" and susceptible to dental caries. No dental anomalies were reported for eight of the nine 5q linked families.
Because ABI Prism marker panels are designed to cover an entire chromosome at an interval of approximately 10 cM intervals, a second round of mapping with additional markers was done in an eVort to reduce and refine the 5q critical region and to produce a linkage map of the new Usher II locus. Haplotypes of 5q markers were constructed for all 12 families. Nine were compatible with linkage to 5q and two showed no linkage (843 was inconclusive). Figs 2, 3, and 4 depict family Examination of the haplotype data shows that the Usher gene is excluded from D5S428 proximal (subject 2) and from D5S433 distal (subject 4) in family 735. Our haplotype data reflect the gene order D5S505-D5S654-D5S485-D5S433. Although the Genome Data Base (GDB) comprehensive genetic map (http://www.gdb.org/gdb-bin/ custom) lists probable gene order as D5S505-D5S433-D5S654-D5S485, localisation of the respective markers is not precise. Exclusion mapping with our families currently places D5S485 proximal to D5S433. The previously reported position of D5S433 at 112.2 cM is relatively close to D5S485 at 112.8 cM. 17 It is likely that future high resolution linkage mapping of the new Usher II gene will resolve the position of D5S485 relative to D5S433. Fig 5 illustrates a composite linkage map (in cM) of the 5q14-q21 region, which was constructed using data from the following sources: the recently updated NCBI Genemap'99 and the NCBI STS database (http:// www2.ncbi.nlm.nih.gov/irx), the WI-CGR STS database, GDB, the Marshfield chromosome 5 sex averaged linkage map (http:// www.marshmed.org/genetics), the Human Genome Research Center-University of California Irvine (HGRC-UCI) chromosome 5 radiation hybrid map (http// www.chrom5.hsis.uci.edu), and our own linkage data. We estimate that the new Usher II gene lies within the chromosomal area flanked by D5S428 and D5S433 which spans approximately 16.8 cM (NCBI Genemap'99). High resolution mapping with additional 5q markers may expedite the identification and characterisation of this Usher II gene. The HUGO nomenclature committee has oYcially designated the Usher II locus on 5q14-q21 as "USH2C".
The transcription factor COUP-TFI was evaluated as a potential candidate when it was found to lie between the flanking markers that delineate the 5q locus (HGRC-UCI chromosome 5 radiation hybrid map, NCBI Genemap'99). PCR primers were designed from COUP-TFI mRNA sequence (GenBank accession number X12795). These primers were used directly to determine the intron-exon structure of the COUP-TF1 by sequencing corresponding PAC and BAC clones. Then, intronic primers were designed and used to amplify genomic DNA from aVected subjects in five of the nine 5q linked families. No mutations were discovered in these five families (data not shown); four have not been screened to date. D5S618  D5S644  D5S484  D5S495   D5S456   D5S409   D5S505  D5S654  D5S485  D5S433   D5S2029   D5S2084  D5S2051  D5S1965   201  180   285  229  148  111  133  260  272   93   134   147   178  246  268   177   91   176   281  229  154  109  135   272  122   262   151   178  238  280   D5S617  D5S618  D5S644  D5S484  D5S495   D5S456   D5S409   D5S505  D5S654  D5S485  D5S433   D5S2029   D5S2084  D5S2051  D5S1965   201  180   285  229  148  111  133  260  272   93   134   147   178  246  268   177  174  81  277  229  148  113  135  256  276  140   135   178  240  268   177  176   281  229  154  109  135  262  272   91   122   151   178  238  268   201  176  97  281   148   247   113  139  264  274  136   143   178  240  270   177  176   281  229  154  109  135  262  272   91   122   151   178  238  280   201  176  97  281  247  148  113  139  264  274  136   143   178  240  268   201  180   285  229  148  111  133  260  272   93   134   147   178  246  268   201  176  97  281  229  148  113  135  256  276  140   143   178  240  270   177  176   281  229  154  109  135  262  272   91   122   151   178  238  280   143  201  176  97  281  247  148  113  139  264  274  136  178  240  268   177  174   277  229  148  113  135  256  276   81   140   135   178  240  270   143  201  176  97  281  247  148  113  139  264  274  136  178  240 An atypical Usher III family with mutations in myosin VIIa (USH1B) and a mild retinal phenotype has been described by Liu et al. 20 The proband presented with a severe to profound hearing loss, normal vestibular function, and RP diagnosed at 38 years. This family was unlinked to USH3, but was compatible for linkage to USH1B. Mutation analysis with DNA sequencing and SSCP analysis showed that both aVected sibs had a maternal Leu651Pro substitution in exon 17 and a paternal Arg1602Gln in exon 35. In the absence of functional testing, it is diYcult to be certain whether either of these missense mutations is truly pathological. Furthermore, this family was not genotyped with 1q41 markers. In light of our findings of a milder RP in 5q linked Usher II families, it would be interesting for this family to be genotyped for markers flanking the 5q Usher II locus as well.
Computer searches of the Mouse Genome Database (http://www.informatics.jax.org), the NCBI Davis mouse/human homology map (http://www.ncbi.nlm.gov/OMIM/homology), and the Human-Mouse Dysmorphology Database (http://www.hgmp.mrc.ac.uk/dhmhd) were done to predict the position of the murine version of the Usher II gene on human 5q14-q21. Mouse chromosome 13 homology group 46 listed in the NCBI Davis Homology Map appears to be the most likely homologous location.
Murine transcripts of coup-tf1 (currently known as erbal3) have been localised to various regions of the central and peripheral nervous system including the inner ear. 21 erbal3 is located on the distal part of mouse chromosome 13 near mef2c, 22 in a region homologous to human 5q14. Although we have seen no evidence supporting COUP-TF1 as an Usher II gene so far, there are not enough data to rule out COUP-TF1's involvement as yet, and erbal3 on mouse chromosome 13 may be a murine positional candidate. COUP-TFI belongs to the steroid/thyroid hormone receptor superfamily, which modulates thyroid hormone, vitamin D, and retinoic acid signalling pathways.
Future research in Usher syndrome type II must address both the substantial phenotypic and genetic heterogeneity of Usher II subtypes. An in depth clinical study is needed to corroborate the phenotypic diVerences we observed in our Usher II series. All putative Usher II families should be genotyped with 5q markers and examined for dental anomalies. Ascertainment of additional unlinked Usher II families with severe, early onset RP and enamel hypoplasia will increase the likelihood of a successful genome search for yet another Usher II gene. 
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